DE69841687D1 - Erythrovirus und ihre verwendung - Google Patents

Erythrovirus und ihre verwendung

Info

Publication number
DE69841687D1
DE69841687D1 DE69841687T DE69841687T DE69841687D1 DE 69841687 D1 DE69841687 D1 DE 69841687D1 DE 69841687 T DE69841687 T DE 69841687T DE 69841687 T DE69841687 T DE 69841687T DE 69841687 D1 DE69841687 D1 DE 69841687D1
Authority
DE
Germany
Prior art keywords
erythrovirus
sequences
fragments
methods
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841687T
Other languages
English (en)
Inventor
Quang Tri Nguyen
Antoine Garbarg-Chenon
Veronique Auguste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Application granted granted Critical
Publication of DE69841687D1 publication Critical patent/DE69841687D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69841687T 1997-12-03 1998-12-03 Erythrovirus und ihre verwendung Expired - Lifetime DE69841687D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715197A FR2771751B1 (fr) 1997-12-03 1997-12-03 Erythrovirus et ses applications
PCT/FR1998/002615 WO1999028439A2 (fr) 1997-12-03 1998-12-03 Erythrovirus et ses applications

Publications (1)

Publication Number Publication Date
DE69841687D1 true DE69841687D1 (de) 2010-07-08

Family

ID=9514085

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841687T Expired - Lifetime DE69841687D1 (de) 1997-12-03 1998-12-03 Erythrovirus und ihre verwendung

Country Status (12)

Country Link
US (2) US7291452B1 (de)
EP (1) EP1037916B1 (de)
JP (1) JP4831864B2 (de)
AT (1) ATE469169T1 (de)
AU (1) AU757453B2 (de)
CA (1) CA2311297C (de)
DE (1) DE69841687D1 (de)
DK (1) DK1037916T3 (de)
ES (1) ES2348203T3 (de)
FR (1) FR2771751B1 (de)
PT (1) PT1037916E (de)
WO (1) WO1999028439A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771751B1 (fr) * 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
US6642033B1 (en) * 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
CA2456715A1 (en) 2001-08-31 2003-03-13 Gen-Probe Incorporated Assay for detection of human parvovirus b19 nucleic acid
CA2559949C (en) * 2004-02-10 2014-04-08 F. Hoffmann-La Roche Ag New primers and probes for the detection of parvovirus b19
US20060057643A1 (en) * 2004-09-10 2006-03-16 Mccarthy Laurence R Methods and compositions for detecting erythrovirus genotypes
AU2005333163B2 (en) 2004-11-09 2011-06-16 Gen-Probe Incorporated Compositions and methods for detecting Group A streptococci
WO2007096199A2 (en) * 2006-02-22 2007-08-30 Ikdt Institut Kardiale Diagnostik Und Therapie Gmbh Differential diagnostics and therapy of virally induced heart muscle disease
CA2673770A1 (en) 2007-01-16 2008-07-24 Talecris Biotherapeutics, Inc. Human erythrovirus
WO2009038840A2 (en) * 2007-06-14 2009-03-26 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
EP3257859B1 (de) 2009-02-26 2020-09-23 Gen-Probe Incorporated Assay zum nachweisen menschlicher parvoviren-nukleinsäure
US9598739B1 (en) 2009-03-13 2017-03-21 Grifols Therapeutics Inc. Human erythrovirus
US20130171185A1 (en) 2010-07-06 2013-07-04 Ethan Settembre Norovirus derived immunogenic compositions and methods
JP6150795B2 (ja) * 2011-07-15 2017-06-28 ジェン−プロウブ インコーポレイテッド シングルプレックス又はマルチプレックスアッセイにおいてヒトパルボウイルス核酸を検出及びａ型肝炎ウイルス核酸を検出するための組成物及び方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322417A1 (de) 1986-09-08 1989-07-05 Applied Biotechnology, Inc. Leere virus kapsidvakzine
CA2002839C (en) 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
US6204044B1 (en) 1989-09-14 2001-03-20 Caroline Sarah Brown Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
US6379885B1 (en) 1989-09-14 2002-04-30 Rijksuniversiteit Te Leiden Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
NL8902301A (nl) 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
US6274307B1 (en) * 1990-02-08 2001-08-14 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active peptides or polypeptides from the parvovirus B19
DE4003826C2 (de) * 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
JPH07147986A (ja) * 1992-09-24 1995-06-13 Denki Kagaku Kogyo Kk ヒトパルボウイルス遺伝子、それによってコ−ドされるポリペプチド及び用途
EP0783580A2 (de) * 1994-09-22 1997-07-16 Wolf, Hans Joachim Nichtstruktureler leserrahmen i dna sequenz und protein aus menschlichem parvovirus b19
FR2771751B1 (fr) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
DE10030677A1 (de) 2000-02-15 2001-08-16 Peter Hechler Schuhwerk mit einer Decksohle
US6668044B1 (en) 2000-07-19 2003-12-23 Xtend Communications Corp. System and method for recording telephonic communications

Also Published As

Publication number Publication date
US7291452B1 (en) 2007-11-06
EP1037916B1 (de) 2010-05-26
AU757453B2 (en) 2003-02-20
JP4831864B2 (ja) 2011-12-07
CA2311297A1 (fr) 1999-06-10
ES2348203T3 (es) 2010-12-01
FR2771751A1 (fr) 1999-06-04
AU1440399A (en) 1999-06-16
US8105610B2 (en) 2012-01-31
WO1999028439A3 (fr) 1999-07-22
JP2001525163A (ja) 2001-12-11
DK1037916T3 (da) 2010-09-27
US20080248528A1 (en) 2008-10-09
ATE469169T1 (de) 2010-06-15
WO1999028439A2 (fr) 1999-06-10
EP1037916A2 (de) 2000-09-27
FR2771751B1 (fr) 2000-05-26
PT1037916E (pt) 2010-08-30
CA2311297C (fr) 2012-10-02

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69841687D1 (de) Erythrovirus und ihre verwendung
ID18046A (id) Senyawa siklik campuran, pembuatan dan penngunaannya.
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
DK1091975T3 (da) Ny cyclosporin med forbedret aktivitetsprofil
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
TR200001835T2 (tr) Aşı.
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
BR0214787A (pt) Compósitos elastoméricos, combinações de elastÈmeros e métodos
EA200200565A1 (ru) Применение клеток, трансфицированных днк, кодирующей лиганд мнс класса ii, и способ получения таких клеток
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
ATE369429T1 (de) Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
FR2831442B1 (fr) Composition cosmetique mimant le sebum, et utilisations
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2002072787A3 (en) Telomerase expression repressor proteins and methods of using the same
WO2003000916A3 (en) Telomerase expression repressor proteins and methods of using the same
DE69809930D1 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
ID23784A (id) Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.
ID23856A (id) Rangkaian dna, ekspresi rangkaian dna, lakase termofilik yang diberi kode oleh rangkaian dna, dan penggunaan daripadanya
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
ATE528392T1 (de) Neues protein und dessen dns
BR9611904A (pt) Dioxidos de ditiazol
SE0004892D0 (sv) Group 2 allergen specific IgE-Fabs and use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition